Rating Change
Piper Sandler reiterated its Overweight rating on Codexis, Inc. (NASDAQ:CDXS) on August 17, 2026.
reiterateNASDAQ:CDXS
Piper Sandler Reiterates Overweight Rating on Codexis, Inc. (CDXS)
Piper Sandler reiterated its Overweight rating on Codexis, Inc. (NASDAQ:CDXS) on August 17, 2026.
At publication ·
What changed
Codexis, Inc. (NASDAQ:CDXS) · reiterate
- Firm
- Piper Sandler
- Rating
- Overweight to Overweight
- Price at event
- $1.59
- Market capitalization
- $144.2M
At a glance
Key takeaways
- Piper Sandler reiterated an Overweight rating on Codexis (CDXS) on August 17, 2026, with the stock trading at $1.59 and a market capitalization of $144.2 million.
Market Context
Codexis, Inc. operates in the Healthcare sector. The stock currently trades at $1.59 with a market capitalization of $144.2M.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Codexis, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Codexis, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | Piper Sandler | Overweight | N/A |
| Nov 22, 2024 | Cantor Fitzgerald | Overweight | N/A |
| Nov 15, 2024 | Cantor Fitzgerald | Overweight | N/A |
| Nov 04, 2024 | Benchmark | Hold | N/A |
| Sep 20, 2024 | Cantor Fitzgerald | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View CDXS Stock Page
Frequently Asked Questions
What does the Overweight rating mean for CDXS?
A rating of Overweight from Piper Sandler reflects the analyst's outlook on Codexis, Inc. (NASDAQ:CDXS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CDXS forecast page.